| Advantages | These organoids exhibit long-term viability and support continuous expansion while maintaining intratumoral heterogeneity and in vivo-like architecture. They provide a highly reliable, physiologically relevant platform for studying cervical cancer progression and therapeutic responses in a controlled setting. |
| Species | Human |
| Product Type | Tissue-derived Organoid |
| Growth Properties | Embedded 3D Culture |
| Growth Conditions | Cultured at 37°C under 95% air and 5% CO2. |
| Quality Control | Negative for mycoplasma, bacteria, yeast, and fungi. |
| Tissue | Cervical |
| Disease | Cancer |
| Format | Frozen |
| Organoid Characterization | Generated from cancer stem-like cells, they faithfully preserve the histopathological structure, molecular alterations, and HPV-related genetic signatures of the original tumor. |
| Applications | Human cervical cancer organoids support a wide range of applications, including antiviral therapy evaluation, anti-cancer drug screening, radiotherapy resistance research, and biomarker discovery for early diagnosis. They are particularly valuable for studying HPV-driven oncogenesis and testing immunotherapy strategies, such as immune checkpoint inhibitors or co-culture with tumor-infiltrating lymphocytes. |
| Storage | Liquid Nitrogen |
| Shipping Information | Dry Ice |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.